Los Angeles Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $435K | Buy |
+8,552
| New | +$435K | ﹤0.01% | 906 |
|
|
2024
Q2 | – | Sell |
-41,836
| Closed | -$1.05M | – | 1243 |
|
|
2024
Q1 | $1.05M | Buy |
41,836
+4,069
| +11% | +$102K | ﹤0.01% | 673 |
|
|
2023
Q4 | $1.11M | Sell |
37,767
-4,677
| -11% | -$138K | ﹤0.01% | 640 |
|
|
2023
Q3 | $1.34M | Buy |
42,444
+494
| +1% | +$15.6K | 0.01% | 540 |
|
|
2023
Q2 | $1.09M | Buy |
+41,950
| New | +$1.09M | ﹤0.01% | 635 |
|
|
2022
Q4 | – | Sell |
-17,533
| Closed | -$368K | – | 1245 |
|
|
2022
Q3 | $368K | Sell |
17,533
-12,087
| -41% | -$254K | ﹤0.01% | 1015 |
|
|
2022
Q2 | $576K | Buy |
+29,620
| New | +$576K | ﹤0.01% | 912 |
|
|
2022
Q1 | – | Sell |
-21,575
| Closed | -$344K | – | 1461 |
|
|
2021
Q4 | $344K | Sell |
21,575
-835
| -4% | -$13.3K | ﹤0.01% | 1189 |
|
|
2021
Q3 | $446K | Buy |
22,410
+1,470
| +7% | +$29.3K | ﹤0.01% | 1111 |
|
|
2021
Q2 | $362K | Buy |
20,940
+1,666
| +9% | +$28.8K | ﹤0.01% | 1315 |
|
|
2021
Q1 | $382K | Buy |
+19,274
| New | +$382K | ﹤0.01% | 1337 |
|